Keywords: taxol, cleared, first-line, use, ovarian, cancer, bristol-myers

Taxol Cleared For First-Line Use In Ovarian Cancer

Article | 28 October 1996

Print This

Bristol-Myers Squibb has been granted approval in the UK to market its anticancer drug Taxol (paclitaxel) for first-line treatment, in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in